Confluence Investment Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
Confluence Investment Management's CLB Position: Q1 2025 in Review
Confluence Investment Management sold out of Core Laboratories (CLB) in Q1 2025, closing a stake of 136,359 shares — an estimated $2.36M sold.
Confluence Investment Management first reported a position in CLB in Q2 2021 and held it in 15 quarters. The position peaked at $9.82M in Q2 2021. 195 funds tracked by Wall St. Rank hold CLB as of Q1 2025.
- Confluence Investment Management reported no remaining Core Laboratories position as of Q1 2025 after selling out during the quarter.
- Confluence Investment Management sold 136,359 Core Laboratories shares in Q1 2025, an estimated $2.36M.
- Confluence Investment Management first reported a position in Core Laboratories in Q2 2021 and held it in 15 quarters.
- Confluence Investment Management's Core Laboratories position peaked at $9.82M in Q2 2021.
- 195 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2025.
Based on Confluence Investment Management's 13F filing for Q1 2025, filed 1 Apr 2025.